Long-term results (60 months) of anti-VEGF therapy of macular diseases in real clinical practice. Part 2.
Purpose: to study long-term results of anti-VEGF therapy for macular diseases of patients followed up for 60 months in real clinical practice. Materials and methods. The research group included 57 patients (43 women, 14 men; median age 62 years) who received antiVEGF therapy (ranibizumab, aflibercep...
Saved in:
| Main Authors: | E. V. Bobykin, R. V. Buslaev, V. Y. Krokhalev, O. V. Morozova, N. S. Beresneva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Real Time Ltd
2022-12-01
|
| Series: | Российский офтальмологический журнал |
| Subjects: | |
| Online Access: | https://roj.igb.ru/jour/article/view/1091 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term results (60 months) of anti-VEGF therapy of macular diseases in real clinical practice. Part 1
by: E. V. Bobykin, et al.
Published: (2022-09-01) -
The impact of switching from anti-VEGF therapy to dexamethasone intravitreal implant on refractory macular edema in patients with retinal vein occlusion: A systematic review and meta-analysis
by: He-Ping Zhang, et al.
Published: (2025-08-01) -
Factors determining the compliance of patients receiving anti-VEGF therapy for macular diseases with long-term follow-up in real-life practice
by: E. V. Bobykin, et al.
Published: (2021-03-01) -
One-year results of visual response following intravitreal novel anti-VEGF injection for diabetic macular edema in a Latino population
by: Guillermo Salcedo-Villanueva, et al.
Published: (2025-08-01) -
Visual Acuity Outcomes and Influencing Factors in a Cohort of UK Real-World Diabetic Macular Oedema Patients During the First Two Years of Anti-VEGF Treatment
by: Qing Wen, et al.
Published: (2025-01-01)